NCT04087473View on ClinicalTrials.gov

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung CancerALK-Positive Lung Cancer
Trial Locations (5)

169690

RECRUITING

National Cancer Center Singapore, Singapore

Unknown

NOT_YET_RECRUITING

The Chinese University of Hong Kong, Hong Kong

RECRUITING

University Malaya Medical Centre, Kuala Lumpur

NOT_YET_RECRUITING

Seoul National University Hospital, Seoul

05505

NOT_YET_RECRUITING

Asan Medical Centre, Seoul

Sponsors
All Listed Sponsors
collaborator

Guardant Health AMEA, Inc.

UNKNOWN

lead

National Cancer Centre, Singapore

OTHER